Flu & Viruses
-
Nasal COVID antibodies short-lived
The next generation of COVID vaccines should include nasal sprays because other vaccines have limited impact on protective levels in the nose, British researchers have suggested. Read more
-
Long COVID rehabilitation programme a success
A rehabilitation programme for people with long COVID has yielded “impressive” results, UK researchers report today. Read more
-
Insight into time of day effect of vaccines
The circadian clock influences response to vaccines, with immune cells behaving differently depending on the time of day, according to a new analysis. Read more
-
Off-patent drug ‘an important weapon’ against COVID-19
An off-patent drug that is used to treat liver disease could be an “important weapon” against COVID-19, according to a new study published last night. Read more
-
Children at growing risk from winter infections
Scarlet fever bacteria and flu are posing a serious risk to children this winter, parents have been warned. Read more
-
Early start to influenza epidemic in Europe – WHO
Europe is facing an unusually early flu epidemic together with rising cases of other respiratory viruses, the World Health Organization has warned. Read more
-
Overweight women face long COVID risk
Overweight women are more likely to experience long COVID, new UK research has found. Read more
-
Growing numbers living with undiagnosed HIV in European region
Hundreds of thousands of people in the World Health Organization European region are not getting living with undiagnosed HIV, according to new data, published for World AIDS Day. Read more
-
Virus evolution insights may boost gene therapy
Study of the evolution of viruses in mammals over millions of years may improve the use of viral vectors for gene therapy, researchers have announced. Read more
-
Emergency department virus testing yielding undiagnosed patients
Routine testing in emergency departments for HIV and hepatitis has found hundreds of people who were not receiving treatment, it was announced today. Read more